Clover Health Investments, Corp. (NASDAQ:CLOV) Receives Average Rating of "Hold" from Analysts
Clover Health Investments, Corp. (NASDAQ:CLOV - Get Free Report) has been assigned an average rating of "Hold" from the five brokerages that are presently covering the company, Marketbeat Ratings...
MarketBeat·11h ago
More News
Clover Health Investments (NASDAQ:CLOV) Reaches New 52-Week Low - Time to Sell?
Clover Health Investments (NASDAQ:CLOV) Sets New 52-Week Low - Here's Why...
MarketBeat·2d ago
Canaccord Genuity Group Reiterates Buy Rating for Clover Health Investments (NASDAQ:CLOV)
Canaccord Genuity Group reissued a "buy" rating and issued a $3.70 target price on shares of Clover Health Investments in a report on Tuesday...
MarketBeat·16d ago
Here's Why You Should Retain CLOV Stock in Your Portfolio for Now
Clover Health shows strong membership growth, rising revenues and sustained EBITDA gains from Clover Assistant, though near-term margin pressure remains a risk.
Zacks·16d ago
Traders Buy Large Volume of Put Options on Clover Health Investments (NASDAQ:CLOV)
Clover Health Investments, Corp. (NASDAQ:CLOV - Get Free Report) saw some unusual options trading activity on Friday. Stock traders purchased 132,321 put options on the company. This represents an...
MarketBeat·20d ago
Clover Health Investments (NASDAQ:CLOV) Shares Down 4.8% - Here's Why
Clover Health Investments (NASDAQ:CLOV) Trading Down 4.8% - Here's What Happened...
MarketBeat·21d ago
CLOV Reports MA Membership Growth, Signals GAAP Profitability in 2026
Clover Health posts 53% AEP PPO membership growth, lifts total members to 153,000, and says the momentum positions it for GAAP net income profitability in 2026.
Zacks·21d ago
IRHYTHM HLDGS (IRTC) Moves 5.0% Higher: Will This Strength Last?
IRHYTHM HLDGS (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Zacks·21d ago
Clover Health Investments (NASDAQ:CLOV) Shares Gap Up - Time to Buy?
Clover Health Investments (NASDAQ:CLOV) Shares Gap Up - Here's Why...
MarketBeat·22d ago
Outset Medical (OM) Soars 22.2%: Is Further Upside Left in the Stock?
Outset Medical (OM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.